Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd. has entered into an exclusive distribution agreement with Zimmer Biomet to enhance the reach of its craniofacial products across Europe, the Middle East, Africa, and the Asia Pacific region. The deal is a significant step for Osteopore in the $53.4 million global craniofacial implant market, which is poised for growth, with projections to double in value by 2032. The partnership leverages Zimmer Biomet’s robust sales network and expertise, aiming to expand Osteopore’s market presence and escalate commercialization efforts.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
